CYVAX

CYVAX, an ISU Vaccine Development Laboratory, is a cost-effective and flexible laboratory focused on USDA compliant master seeds, manufacturing scale up, analytical methods, and commercial development of materials that can be used for clinical trials to support a commercial theme. This laboratory has core equipment to allow compliant activities directed toward USDA licensure. The lab would be a multi-tenant facility that could support 4 concurrent companies in their development cycle and this critical phase of company maturation. It is anticipated that as companies become successful, they would transition out of this shared facility into their own dedicated laboratory for long-term commercial success or transfer the technology to another commercial partner. The facility is operated as a not-for-profit with the primary goal of commercial development and supported with expertise from individuals with industry and CVB experience.

For more information on this program or to apply for membership:

Contact

Michael Roof, PhD

Chief Technology Officer
Vaccines, Diagnostics and Immunotherapeutics
Iowa State University

CYVAX Opportunity

Use by ISU faculty to increase the quality of their research and CVB compliance
Iowa based startup access to focus on commercial development without excess capital spending.
Existing industry can leverage the world-class Animal Health faculty, technology and infrastructure in Central Iowa.
Wet-lab training opportunities

Provided Equipment

"CYVAX provides a convenient space to conduct my laboratory research. The proximity to ISU campus allows me easy access to a large pool of very talented undergrad and graduate students to contract for hands-on help. Those working in animal health will appreciate being only minutes away from the experts at ISU College of Veterinary Medicine and the ISU Veterinary Diagnostic Laboratory. And the USDA Center for Veterinary Biologics is in town, too, should I need to reach out to them."

"CyVax has been a key driver of innovation for my group and our ability to deliver quality products to stakeholders and customers. We not only have access to industry leaders and the exceptional core facilities and staff at ISU, but we have also recruited emerging talent through our partnership. This unique opportunity has significantly increased our capabilities with minimal resource investment."

"We were looking for an entry point into the US market. CYVAX gave us a fast and efficient way to join the US and Animal Health Ecosystem. We have been amazed at the talent and technology available"

"The ability to get industry and regulatory guidance to ensure our efforts and technology was compliant and licensable is something invaluable to our efforts"